A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of people being treated for obesity and ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals ... The two relatively new drugs are approved to treat type 2 diabetes and for ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and ...